Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Shares Issued: 2014-2024

Historic Shares Issued for Seres Therapeutics (MCRB) over the last 11 years, with Dec 2024 value amounting to $487,000.

  • Seres Therapeutics' Shares Issued fell 65.67% to $46,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $717,000, marking a year-over-year decrease of 72.82%. This contributed to the annual value of $487,000 for FY2024, which is 77.36% down from last year.
  • As of FY2024, Seres Therapeutics' Shares Issued stood at $487,000, which was down 77.36% from $2.2 million recorded in FY2023.
  • Over the past 5 years, Seres Therapeutics' Shares Issued peaked at $243.7 million during FY2020, and registered a low of $487,000 during FY2024.
  • Its 3-year average for Shares Issued is $33.1 million, with a median of $2.2 million in 2023.
  • Per our database at Business Quant, Seres Therapeutics' Shares Issued tumbled by 99.47% in 2021 and then spiked by 7,345.80% in 2022.
  • Over the past 5 years, Seres Therapeutics' Shares Issued (Yearly) stood at $243.7 million in 2020, then tumbled by 99.47% to $1.3 million in 2021, then skyrocketed by 7,345.80% to $96.7 million in 2022, then slumped by 97.78% to $2.2 million in 2023, then tumbled by 77.36% to $487,000 in 2024.